Morning Overview on MSN
GLP-1 drugs fail to slow Alzheimer’s in 2 major trials
Two of the most closely watched Alzheimer clinical trials of the decade have delivered a sobering verdict: GLP-1 drugs that ...
Merhi reportedly explained a procedure still considered experimental: an injection of platelet-rich plasma, or PRP, into the ...
Targeting receptors for erythropoietin on dendritic cells may be a viable strategy for treating MS and other diseases, ...
From small ions to large molecules, cellular gates control what can pass in and out of cells. But how one such gate, called ...
Issued on behalf of GT Biopharma, Inc.VANCOUVER, BC, Dec. 11, 2025 /PRNewswire/ -- Equity Insider News Commentary – November's wave of FDA oncology ...
Leading synthetic biologists have shared hard-won lessons from their decade-long quest to build the world's first synthetic ...
The International Society for Stem Cell Research (ISSCR) today opened its sold-out international symposium, Accelerating ...
Major histocompatibility complex class II (MHC-II) molecules play a critical, yet historically overlooked, role in tumor ...
A new University of California San Diego School of Medicine study offers a unified biological model to explain how genetic ...
Aging taps us on the shoulder in many ways: wrinkles, thinning hair, loss of flexibility, slowing of the brain. But the ...
Researchers at the Department of Cell and Molecular Biology, Karolinska Institutet have captured the first detailed molecular ...
A new University of California San Diego School of Medicine study offers a unified biological model to explain how genetic ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈